Oncocyte logo

Oncocyte Share Price Today

(NASDAQ: OCX)

Oncocyte share price is $2.84 & ₹242.72 as on 18 Apr 2025, 2.30 'hrs' IST

$2.84

0.01

(0.35%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Oncocyte share price in Dollar and Rupees. Guide to invest in Oncocyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oncocyte, along with analyst recommendations, forecasts, and comprehensive financials.

Oncocyte share price movements

  • Today's Low: $2.76
    Today's High: $2.85

    Day's Volatility :3.15%

  • 52 Weeks Low: $1.92
    52 Weeks High: $4.75

    52 Weeks Volatility :59.54%

Oncocyte (OCX) Returns

PeriodOncocyte CorpSector (Health Care)Index (Russel 2000)
3 Months
33.96%
-2.8%
0.0%
6 Months
-8.97%
-11.0%
0.0%
1 Year
13.6%
-1.9%
0.0%
3 Years
-88.17%
-1.5%
-12.9%

Oncocyte (OCX) Key Statistics

in dollars & INR

Previous Close
$2.83
Open
$2.8499
Today's High
$2.8499
Today's Low
$2.76
Market Capitalization
$81.2M
Today's Volume
$8.0K
52 Week High
$4.75
52 Week Low
$1.922
Revenue TTM
$1.9M
EBITDA
$-21.7M
Earnings Per Share (EPS)
$-4.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-910.86%

How to invest in Oncocyte Stock (OCX) from India?

It is very easy for Indian residents to invest directly in Oncocyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncocyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncocyte or OCX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncocyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncocyte shares which would translate to 0.301 fractional shares of Oncocyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncocyte, in just a few clicks!

Returns in Oncocyte (OCX) for Indian investors in Rupees

The Oncocyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oncocyte investment value today

Current value as on today

₹1,15,941

Returns

₹15,941

(+15.94%)

Returns from Oncocyte Stock

₹13,600 (+13.6%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Oncocyte (OCX)

80%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Oncocyte Stock from India on INDmoney has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oncocyte

  • BROADWOOD CAPITAL Inc

    21.83%

  • Awm Investment Company Inc

    2.71%

  • PURA VIDA INVESTMENTS, LLC

    2.29%

  • Vanguard Group Inc

    0.85%

  • Geode Capital Management, LLC

    0.48%

  • BlackRock Inc

    0.28%

Analyst Recommendation on Oncocyte

Rating
Trend

Buy

    62%Buy

    37%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Oncocyte(by analysts ranked 0 to 5 stars)

Analyst Forecast on Oncocyte Stock (OCX)

What analysts predicted

Upside of 55.52%

Target:

$4.42

Current:

$2.84

Insights on Oncocyte Stock (Ticker Symbol: OCX)

  • Price Movement

    In the last 3 months, OCX stock has moved up by 36.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 104.0K → 1.48M (in $), with an average increase of 50.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -4.53M → -33.51M (in $), with an average decrease of 173.1% per quarter
  • OCX vs A (3 yr)

    In the last 3 years, Oncocyte Corp has experienced a drawdown of -88.4%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 68.7%

Oncocyte Technicals Summary

Sell

Neutral

Buy

Oncocyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Oncocyte (OCX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Oncocyte Corp logo
-14.24%
-8.97%
13.6%
-88.17%
-93.55%
Agilent Technologies Inc. logo
-14.62%
-25.07%
-22.79%
-20.79%
32.45%
Idexx Laboratories, Inc. logo
-4.34%
-9.24%
-13.62%
-19.85%
53.92%
Thermo Fisher Scientific, Inc. logo
-15.78%
-28.2%
-21.53%
-27.68%
30.67%
Danaher Corp. logo
-9.32%
-31.34%
-20.67%
-33.37%
19.89%
Iqvia Holdings Inc. logo
-19.44%
-37.75%
-36.91%
-40.72%
12.86%

About Oncocyte

OncoCyte Corporation, a precision diagnostics company in the United States and internationally. It develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. The company is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. It also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Organization
Oncocyte
Employees
46
CEO
Dr. Michael D. West Ph.D.
Industry
Health Technology

Management People of Oncocyte

NameTitle
Mr. Joshua Riggs
President, CEO & Director
Ms. Andrea Susan James
Chief Financial Officer
Mr. James Liu
VP of Accounting, Treasurer, Senior Director, Controller & Principal Accounting Officer
Dr. Ekkehard Schutz M.D., Ph.D.
Chief Science Officer
Mr. Yuh-Min Chiang Ph.D.
Chief Technology Officer
Mr. Peter Hong
VP, General Counsel & Secretary
Ms. Sandra O'Donald
Senior Vice President of Business Operations
Dr. Paul R. Billings FACP, M.D.
Consulting Chief Medical Officer
Dr. Michael D. West Ph.D.
Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

Important FAQs about investing in OCX Stock from India :

What is Oncocyte share price today?

Oncocyte share price today stands at $2.84, Open: $2.85 ; Previous Close: $2.83 ; High: $2.85 ; Low: $2.76 ; 52 Week High: $4.75 ; 52 Week Low: $1.92.

The stock opens at $2.85, after a previous close of $2.83. The stock reached a daily high of $2.85 and a low of $2.76, with a 52-week high of $4.75 and a 52-week low of $1.92.

Can Indians buy Oncocyte shares?

Yes, Indians can invest in the Oncocyte (OCX) from India.

With INDmoney, you can buy Oncocyte at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oncocyte at zero transaction cost.

How can I buy Oncocyte shares from India?

It is very easy to buy Oncocyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncocyte (OCX) be purchased?

Yes, you can buy fractional shares of Oncocyte with INDmoney app.

What are the documents required to start investing in Oncocyte stocks?

To start investing in Oncocyte, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oncocyte Stock (OCX)?

Today’s highest price of Oncocyte (OCX) is $2.85.

Today’s lowest price of Oncocyte (OCX) is $2.76.

What is today's market capitalisation of Oncocyte?

Today's market capitalisation of Oncocyte OCX is 81.2M

What is the 52 Week High and Low Range of Oncocyte Stock (OCX)?

  • 52 Week High

    $4.75

  • 52 Week Low

    $1.92

What are the historical returns of Oncocyte (OCX)?

  • 1 Month Returns

    -14.24%

  • 3 Months Returns

    -8.97%

  • 1 Year Returns

    13.6%

  • 5 Years Returns

    -93.55%

Who is the Chief Executive Officer (CEO) of Oncocyte ?

Dr. Michael D. West Ph.D. is the current Chief Executive Officer (CEO) of Oncocyte.